Skip to main content
. 2011 Mar 29;117(23):6297–6303. doi: 10.1182/blood-2011-01-332379

Figure 4.

Figure 4

Bortezomib induces the UPR. EBV+ Akata cells were treated with 20nM bortezomib (BZ) and harvested at the indicated time points. Nuclear protein extracts were prepared and subjected to Western blot analysis. Blots were probed for C/EBPβ, ATF4, CHOP10, XBP1(s), ATF6, and ZTA, and for β-actin as a loading control.